# UKONIQ
> **NDA213176** · New Drug Application · Sponsor: TG THERAPS · Approved 2021-02-05
## Drug
- **FDA Application Number:** NDA213176
- **Application type:** New Drug Application
- **Brand name:** UKONIQ
- **Generic name:** Umbralisib Tosylate
- **Active ingredients:** UMBRALISIB TOSYLATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** TG THERAPS
- **First approval:** 2021-02-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213176)
---
*AI Analytics · CC0 1.0*